Taken collectively, our results thus show a mechanistic link between FIC-1-mediated AMPylation and previously observed effects on neurodegenerative disease-associated polypeptides, underscoring the notion that controlling cellular proteostasis by manipulating levels of AMPylation represents a plausible approach to combating protein misfolding diseases. Here, ATP8B1 is linked to proteostasis deficiencies.